Fyodor Biotechnologies

Fyodor is a privately held medical device company whose mission is to develop and commercialize novel medical diagnostic tests that address unmet needs in Nigeria and emerging economies. In response to the large proportion of malaria that is managed at home and in all healthcare settings, Fyodor has developed the Urine Malaria TestTM (UMT) – thefirst ever non-blood (one-step, no blood, no reagents, no equipment, visually read) rapid test that tells in 25 minutes or less if a fever is due to malaria or not. It removes the complexity, pain and risks associated with a blood test.